Navicare Biotech Co., Ltd. (8472) Stock Price & Analysis
8472 Stock Chart & Stats
NT$49.00-NT$5.40(-9.93%)
At close: 11:56 PM EST
- Day’s Range
- TWD 49.00 - TWD 54.40
- 52-Week Range
- TWD 49.00 - TWD 99.00
- Previous Close
- TWD 54.40
- Volume
- N/A
- Average Volume (3M)
- 26.61K
- Market Cap
- TWD 869.05M
- Enterprise Value
- TWD 1.60B
- Total Cash (Recent Filing)
- TWD 165.13M
- Total Debt (Recent Filing)
- TWD 318.39M
- Price to Earnings (P/E)
- ―
- Beta
- 0.37
- Next Earnings
- Nov 16, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 19, 2022
- Dividend Yield
- N/A
8472 FAQ
What was Navicare Biotech Co., Ltd.’s price range in the past 12 months?
Navicare Biotech Co., Ltd. lowest stock price was TWD 49.00 and its highest was TWD 99.00 in the past 12 months.
What is Navicare Biotech Co., Ltd.’s market cap?
Navicare Biotech Co., Ltd.’s market cap is TWD 869.05M.
When is Navicare Biotech Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Navicare Biotech Co., Ltd.’s earnings last quarter?
Navicare Biotech Co., Ltd. released its earnings results on Aug 10, 2026. The company reported -TWD 0.395 earnings per share for the quarter.
Is Navicare Biotech Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Navicare Biotech Co., Ltd. pay dividends?
Navicare Biotech Co., Ltd. pays a ― dividend of TWD 1.5 which represents an annual dividend yield of ―. See more information on Navicare Biotech Co., Ltd. dividends here
What is Navicare Biotech Co., Ltd.’s EPS estimate?
Navicare Biotech Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Navicare Biotech Co., Ltd. have?
Navicare Biotech Co., Ltd. has 17,735,800 shares outstanding.
What happened to Navicare Biotech Co., Ltd.’s price movement after its last earnings report?
Navicare Biotech Co., Ltd. reported an EPS of -TWD 0.395 in its last earnings report. Following the earnings report the stock price went up 2.177%.
Which hedge fund is a major shareholder of Navicare Biotech Co., Ltd.?
Currently, no hedge funds are holding shares in TW:8472
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Navicare Biotech Co., Ltd.
Navicare Biotech Co., Ltd. is a Taiwanese enterprise that specializes in offering digital commerce and marketing solutions. The company operates a comprehensive online platform designed to showcase information for a diverse range of vendors. This digital marketplace features details for businesses such as popular restaurant chains, specialized dining venues, wellness centers including spas and massage parlors, cinemas, and various other establishments within the food, beverage, and entertainment sectors. The company also engages in the wholesale and retail of health supplements and beauty products. Founded in 1999, Navicare Biotech, formerly known as GOMAJI Corp., LTD, maintains its headquarters in New Taipei City, Taiwan.
- Sector
- General
- Industry
- Specialty Retail
- CEO
- Suzhen Chen
- Employees
- 80
- Website
- www.gomaji.com
- Address
- TW
Navicare Biotech Co., Ltd. (8472) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |
